Literature DB >> 29459574

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

Mitsunori Higuchi1, Hironori Takagi2, Yuki Ozaki2, Takuya Inoue2, Yuzuru Watanabe2, Takumi Yamaura2, Mitsuro Fukuhara2, Satoshi Muto2, Naoyuki Okabe2, Yuki Matsumura2, Takeo Hasegawa2, Jun Osugi2, Mika Hoshino2, Yutaka Shio2, Hiroyuki Suzuki2.   

Abstract

BACKGROUND: According to previous reports, lobectomy with bronchoplasty or angioplasty is a more feasible surgery than pneumonectomy for central-type non-small cell lung cancer. However, few studies have compared both the short- and long-term outcomes between pneumonectomy and pulmonary function-preserving surgery.
METHODS: From January 2004 to December 2015, 18 patients underwent pneumonectomy (Group PN) and 12 patients underwent pulmonary function-preserving surgery (group PS) at Fukushima Medical University Hospital. Clinicopathological factors were statistically compared between the two groups.
RESULTS: The operation times in Group PN and Group PS were 285.9±27.9 and 271.3±99.2 min, respectively (p=0.613), while the amounts of intraoperative bleeding were 324.8±248.9 and 164.5±116.6 g, respectively (p=0.020). The duration of chest drainage and hospitalization after surgery in both groups were not significantly different but there was a tendency toward shorter periods of these durations in Group PS. The 5-year disease-free survival (DFS) rate in Group PN and PS was 51.4% and 74.1%, respectively, without a significant difference (p=0.298). The 5-year overall survival (OS) rate in Group PN and PS was 52.5% and 56.6%, respectively, also without a significant difference (p=0.748). The 5-year OS rate was inferior to the 5-year DFS rate in Group PS, and the 5-year OS rate was not better than the 5-year DFS rate in Group PN.
CONCLUSIONS: The short-term results were better in Group PS than PN. However, the long-term results in both groups were similar. Other causes of death influenced OS in both groups; this result might have been affected by the surgical procedures.

Entities:  

Keywords:  Angioplasty; Bronchoplasty; Non-small cell lung cancer (NSCLC); Pneumonectomy; Surgical outcomes

Mesh:

Year:  2018        PMID: 29459574      PMCID: PMC5956088          DOI: 10.5387/fms.2017-10

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  20 in total

1.  Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.

Authors:  M Okada; H Yamagishi; S Satake; H Matsuoka; Y Miyamoto; M Yoshimura; N Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2000-04       Impact factor: 5.209

2.  Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques.

Authors:  Mark K Ferguson; Amy G Lehman
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

3.  Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.

Authors:  Jean Deslauriers; Jocelyn Grégoire; Louis F Jacques; Michel Piraux; Liu Guojin; Yves Lacasse
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

4.  Risk stratification for lung cancer surgery: impact of induction therapy and extended resection.

Authors:  Yoko Matsubara; Shin-ichi Takeda; Takashi Mashimo
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

Review 5.  Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy.

Authors:  M Tedder; M P Anstadt; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

6.  Bronchial and bronchovascular sleeve resection for treatment of central lung tumors.

Authors:  H F Lausberg; T P Graeter; O Wendler; S Demertzis; D Ukena; H J Schäfers
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

7.  Pneumonectomy for malignant disease: factors affecting early morbidity and mortality.

Authors:  A Bernard; C Deschamps; M S Allen; D L Miller; V F Trastek; G D Jenkins; P C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 5.209

8.  Tumor stage and early mortality for surgical resections in lung cancer.

Authors:  Erich Stoelben; Willi Sauerbrei; Corinna Ludwig; Joachim Hasse
Journal:  Langenbecks Arch Surg       Date:  2003-02-22       Impact factor: 3.445

9.  Survival related to nodal status after sleeve resection for lung cancer.

Authors:  R J Mehran; J Deslauriers; M Piraux; M Beaulieu; C Guimont; J Brisson
Journal:  J Thorac Cardiovasc Surg       Date:  1994-02       Impact factor: 5.209

10.  Thoracic and cardiovascular surgery in Japan during 2013: Annual report by The Japanese Association for Thoracic Surgery.

Authors:  Munetaka Masuda; Hiroyuki Kuwano; Meinoshin Okumura; Hirokuni Arai; Shunsuke Endo; Yuichiro Doki; Junjiro Kobayashi; Noboru Motomura; Hiroshi Nishida; Yoshikatsu Saiki; Fumihiro Tanaka; Kazuo Tanemoto; Yasushi Toh; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.